Current role
Biotechnology · Healthcare
Board Member
2026-06-01–present
Benjamin F. Cravatt, Ph.D.
Board Member
Alnylam Pharmaceuticals, Inc. (ALNY)Equibles does not estimate personal net worth.
Get an email with a short summary when Alnylam Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALNY alertsAbout Benjamin F. Cravatt, Ph.D.
Benjamin F. Cravatt, Ph.D. is recorded as Board Member at Alnylam Pharmaceuticals, Inc. (ALNY) since June 1, 2026. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Amy W. Schulman (Chairman and Board Member) and 7 others.
Affiliation history
-
Current
2026-06-01–present
Company network
Leadership on record at Alnylam Pharmaceuticals, Inc.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Carolyn R. Bertozzi Board Member
Recent activity
No call appearances or filed executive changes recorded yet.